drugset / Trial / NCT03702491
Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
RandomizedParallel-groupOpen-labelTreatment
Summary
A Single-center Open, Randomized, Controlled Study to Compare the Apapitatin Mesylate Combined With SOX Regimen and SOX Regimen for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
Timeline
- Start
- 2018-08-10
- Primary completion
- 2020-08-10
- Completion
- 2020-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | — | — |
| Background | Oxaliplatin | Small molecule | — | — |
| Comparator | S-1 | Small molecule | — | — |